HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $3 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Precision BioSciences (NASDAQ:DTIL) and maintained a $3 price target.
September 19, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a 'Buy' rating on Precision BioSciences and maintained a $3 price target, potentially indicating positive sentiment towards the stock.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. The reiteration of a 'Buy' rating and maintenance of a $3 price target by HC Wainwright & Co. suggests they believe the stock is undervalued at current prices, which could lead to increased buying pressure and a potential increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100